Eyecbetter announces Amy Dixon, PLY (Paralympian), as new Director of Patient Advocacy
September 23rd 2023As a gold medalist with profound vision loss, she will lead advocacy efforts for people with glaucoma that are designed to empower patients to participate actively in their glaucoma treatment journey
Study: MERCURY-3 trial results support efficacy of Roclanda
September 16th 2023MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.